Save
Neurobiology of multiple sclerosis: from basic science to clinical translation
ECTRIMS Online Library, Catherine Lubetzki, 232078
Scientific highlights
ECTRIMS Online Library, Scott Zamvil, 232082
Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis
ECTRIMS Online Library, Klemens Ruprecht, 232073
Vitamin D, smoking, EBV and long-term cognitive performance among CIS patients: 11-year follow-up of BENEFIT
ECTRIMS Online Library, Marianna Cortese, 232074
Primary analysis of a randomised, placebo-controlled, phase 2 study of the Bruton's tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing multiple sclerosis
ECTRIMS Online Library, Xavier Montalban, 232075
A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as add-on therapy for neuromyelitis optica spectrum disorder (NMOSD)
ECTRIMS Online Library, Takashi Yamamura, 232076
MS-SMART Trial: a multi-arm phase 2b randomised, double blind, parallel group, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis [NCT01910259]
ECTRIMS Online Library, Jeremy Chataway, 232077
Automated assessment of new and enlarged white matter and cortical lesions in early multiple sclerosis
ECTRIMS Online Library, Mário João Fartaria, 229577
Which subgroups of progressive MS should be treated?
ECTRIMS Online Library, Xavier Montalban, 232037
Update on neuroprotection trials in progressive MS
ECTRIMS Online Library, Robert J. Fox, 232038
Neurofilament light levels in the blood of patients with secondary progressive MS are higher than in primary progressive MS and may predict brain atrophy in both MS subtypes
ECTRIMS Online Library, Ludwig Kappos, 232039
Slowly evolving lesions and relation to disability in a SPMS cohort
ECTRIMS Online Library, Alberto Calvi, 232040
A molecular characterization of meningeal inflammatory infiltrates in the progressive multiple sclerosis brain
ECTRIMS Online Library, Laura Fuentes Font, 232041
Efficacy, safety and tolerability of IB-MS versus placebo in patients with progressive forms of MS: preliminary results from a phase II, randomized, placebo-controlled, double blind, proof of concept study
ECTRIMS Online Library, Ethel Ciampi, 232042
Pathologic evidence for disease heterogeneity
ECTRIMS Online Library, Wolfgang Brück, 232043
MRI evidence for disease heterogeneity
ECTRIMS Online Library, Daniel S. Reich, 232044
Diffusion basis spectrum imaging for identifying subtypes of multiple sclerosis
ECTRIMS Online Library, Afsaneh Shirani, 232045
Peripapillary hyperreflective ovoid mass-like structures in multiple sclerosis are associated with disease progression
ECTRIMS Online Library, Axel Petzold, 232046
Clinical features of patients with anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive optic neuritis with a certain antibody-binding epitope on human MOG extracellular domain
ECTRIMS Online Library, Keiko Tanaka, 232047
Evaluation of treatment response in adults with relapsing MOG-Ab- associated disease
ECTRIMS Online Library, Alvaro Cobo-Calvo, 232048
From MS genetics to pathogenetic concepts
ECTRIMS Online Library, Lars Fugger, 232049
MultiOMics in MS
ECTRIMS Online Library, Chris Cotsapas, 232050
DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis
ECTRIMS Online Library, Lisa Ann Gerdes, 232051
Multiple sclerosis associated SNPs influencing B cell expression of co-stimulatory receptors and T cell proliferation and cytokine secretion profile
ECTRIMS Online Library, Di He, 232052
Single-cell RNA-sequencing identifies putative multiple sclerosis-associated microglial subtypes
ECTRIMS Online Library, Vilas Menon, 232053
Bile acid metabolism is altered in MS and supplementation leads to amelioration of neuroinflammation
ECTRIMS Online Library, Pavan Bhargava, 232054
Genetic mimicks with acute presentation
ECTRIMS Online Library, O. Boespflug-Tanguy, F. Mochel, 232055
Structural connectivity
ECTRIMS Online Library, Menno Schoonheim, 232059
Functional connectivity
ECTRIMS Online Library, Maria Assunta Rocca, 232060
Clinical significance
ECTRIMS Online Library, Declan Chard, 232061
Making it Real
ECTRIMS Online Library, Montalban, Sormani, Tackenberg, Kitzler, 234259
How to define treatment failure?
ECTRIMS Online Library, Jaume Sastre-Garriga, 232013
Strategies for switching therapy: how good is the evidence?
ECTRIMS Online Library, Fred Lublin, 232014
Value of serum neurofilament light chain levels as a biomarker of suboptimal treatment response in MS clinical practice
ECTRIMS Online Library, Özgür Yaldizli, 232015
Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy
ECTRIMS Online Library, Thor Ameri Chalmer, 232016
Alemtuzumab after natalizumab SWitch in evolving rapidly severe multiple sclerosis (ANSWERS MS): long-term UK & Ireland experience
ECTRIMS Online Library, Paul Gallagher, 232017
Shift from fingolimod to alemtuzumab: what happens next?
ECTRIMS Online Library, Jessica Frau, 232018
Recent developments in spinal cord imaging
ECTRIMS Online Library, Olga Ciccarelli, 232019
Atrophy
ECTRIMS Online Library, Maria Assunta Rocca, 232020
Cranio-caudal patterns of cervical cord atrophy progression in MS according to disease phenotype and clinical worsening: a multicenter study
ECTRIMS Online Library, Maria Assunta Rocca, 232021
7T MP2RAGE MRI for assessment of myelination status in white matter lesions of multiple sclerosis
ECTRIMS Online Library, Hadar Kolb, 232022
Remyelination fails in the periventricular white matter in MS
ECTRIMS Online Library, Emilie Poirion, 232023
In vivo assessment of myelin breakdown pattern in multiple sclerosis: a hybrid PET/MR [18F]florbetaben study
ECTRIMS Online Library, Antonio Carotenuto, 232024
Robot-assisted training in MS
ECTRIMS Online Library, Peter Feys, 232025
Telehealth applications for supporting exercise behavior in MS
ECTRIMS Online Library, Robert Motl, 232026
A comparison of human and digital speech analysis to describe and monitor cerebellar dysfunction and disease severity in multiple sclerosis
ECTRIMS Online Library, Gustavo Noffs, 232027
Association of a technology-enabled 9-Hole Peg Test with patient reported outcomes and Imaging metrics in a large multiple sclerosis clinic population
ECTRIMS Online Library, Laura Baldassari, 232028
Can motor fatigue be measured? - On the relation of fatigue trait, perceived exertion, and gait analysis measures after 6minute walking
ECTRIMS Online Library, Daniel Drebinger, 232029
Novel multi-sensor algorithm captures subtle progression over one year in multiple sclerosis
ECTRIMS Online Library, Kristen M Krysko, 232030
NMOSD and AQP4-Ab positive disease classification and update on epidemiology and phenotypic features
ECTRIMS Online Library, Friedemann Paul, 232031
MOG antibody disease update and differentiation from MS and AQP4-Ab positive disease
ECTRIMS Online Library, Kazuo Fujihara, 232032
Treatment of NMOSD using case studies
ECTRIMS Online Library, Jacqueline Palace, 232033
Overview of the rationale and the options of stem cells therapies in MS and review of the existing clinical experience
ECTRIMS Online Library, Dimitrios Karussis, 232034
Mesenchymal stem cells in MS: possible mechanisms of action and future directions
ECTRIMS Online Library, Antonio Uccelli, 232035
The rationale and the existing clinical data using haematopoietic stem cells in MS
ECTRIMS Online Library, Paolo A. Muraro, 232036
Treatment sequencing in MS: how do you choose the right DMD for your patient?
ECTRIMS Online Library, Christoph Kleinschnitz, 232008
Did risk stratification modify the incidence of PML in natalizumab-treated MS patients in France?
ECTRIMS Online Library, Sandra VUKUSIC, 228124
Alemtuzumab reduces serum neurofilament light chain levels in relapsing-remitting multiple sclerosis patients from the CARE-MS I study
ECTRIMS Online Library, Jens Kuhle, 228125
Synaptic protection in EAE gray matter with ibudilast and URMC-099
ECTRIMS Online Library, Matthew Bellizzi, 228140
Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination
ECTRIMS Online Library, Drew Adams, 228156
Double cohort study observed neuropreservation in retinal layers over 5 years after alemtuzumab treatment in relapsing-remitting multiple sclerosis patients
ECTRIMS Online Library, Jillian Katrina Chan, 228173
AQP4-autoimmunity in Japan and Germany - a comparative retrospective study in neuromyelitis optica spectrum disorders
ECTRIMS Online Library, Alexander U. Brandt, 228823
Early clinical predictors of severe MS
ECTRIMS Online Library, Charles Malpas, 228824
A multi-national study of socioeconomic status and disability progression in multiple sclerosis
ECTRIMS Online Library, Katharine Harding, 228839
US-based African Americans with multiple sclerosis have greater disability and lower socio-economic status than Caucasian Americans
ECTRIMS Online Library, Karla Gray-Roncal, 228840
Atypical clinical features as a presentation of multiple sclerosis
ECTRIMS Online Library, Cecilia Pita, 228856
Subclinical cochlear involvement in newly diagnosed relapsing-remitting multiple sclerosis
ECTRIMS Online Library, Maria Albanese, 228857
Systematic multidimensional clinical point-of-care monitoring of people with multiple sclerosis using 3test
ECTRIMS Online Library, Kimberley Allen-Philbey, 228873
Effect of MD1003 (high dose pharmaceutical grade biotin) on remotely monitored ambulatory activity in progressive MS: initial step count data of the phase 3 SPI2 study
ECTRIMS Online Library, Bruce A. Cree, 228874
The systemic sarcoidosis and multiple sclerosis dilemma: Serum Amyloid A in cerebrospinal fluid as a useful marker to exclude neurosarcoidosis out of the equation
ECTRIMS Online Library, Maria Reyes-Mantilla, 228889
Impact of comorbidity and DMT use on disability status by DMT group in participants in the Pacific Northwest MS Registry
ECTRIMS Online Library, Elizabeth Baraban, 228890
The role of interoception in multiple sclerosis fatigue
ECTRIMS Online Library, Iulia Bogdan, 228905
The new in vitro blood-brain barrier (BBB) model under shear forces with multi-culture of BBB components in multiple sclerosis
ECTRIMS Online Library, Yukio Takeshita, 228906
Role of vitamin D in the expression of TGFβ signalling in patients with relapsing remitting multiple sclerosis
ECTRIMS Online Library, José M García-Domínguez, 228921
Single cell transcriptomics identifies an MS-specific composition and expression of cerebrospinal fluid cells
ECTRIMS Online Library, Gerd Meyer zu Hörste, 228922
Imaging of the mechanisms of thalamic damage in pediatric multiple sclerosis
ECTRIMS Online Library, Ermelinda De Meo, 228937
Longitudinal characterization of optic nerve and retinal pathology in experimental autoimmune encephalomyelitis
ECTRIMS Online Library, Praveena Manogaran, 228938
Increased functional efficiency of the sensorimotor network is associated with disability in multiple sclerosis
ECTRIMS Online Library, Myrte Strik, 228953
Thalamic volume predicts disability progression in multiple sclerosis: a 6-year prospective study
ECTRIMS Online Library, Elias S. Sotirchos, 228954
Default Network Index: a novel, clinically-informative marker of memory status in multiple sclerosis
ECTRIMS Online Library, Victoria Leavitt, 228969
TAPAS: threshold adjustment to probability map automatic segmentations
ECTRIMS Online Library, Alessandra M. Valcarcel, 228970
Decrement of brain functional integration in multiple sclerosis is relevant to disability: a graph theory study
ECTRIMS Online Library, Silvia Tommasin, 228985
Using normalized thalamic brain volume and lesion load to identify distinct phenotypes in early relapsing multiple sclerosis patients
ECTRIMS Online Library, Roland Opfer, 228986
Is the EDSS sensitive to SDMT change during relapse in MS: assessment of the CFS component score
ECTRIMS Online Library, Ralph HB Benedict, 229001
Association of cognitive impairment with spinal cord MRI measures in radiologically isolated syndrome
ECTRIMS Online Library, Jiwon Oh, 229002
Modulation of default mode network connectivity occurs in MS patients starting fingolimod or natalizumab: a 2-year resting state functional connectivity study
ECTRIMS Online Library, Maria Assunta Rocca, 229017
Spinal cord lesions correlate with blood sNfL levels in multiple sclerosis
ECTRIMS Online Library, Falk Steffen, 229018
Blood glucose levels modulate dimethyl fumerate-associated neutropenia in MS patients
ECTRIMS Online Library, Myla Denise Goldman, 229033
Switching stable RRMS patients from natalizumab to alemtuzumab - efficacy and safety in the real world
ECTRIMS Online Library, Stephan Richter, 229034
Transcriptional modulation induced by fingolimod treatment in relapsing remitting multiple sclerosis patients
ECTRIMS Online Library, Giacomo Sferruzza, 229049
Lymphocyte changes induces by alemtuzumab in multiple sclerosis patients
ECTRIMS Online Library, Silvia Medina, 229050
P2X7: a target for neuroprotection and neuroinflammation in multiple sclerosis
ECTRIMS Online Library, Ross Gruber, 229066
An integral measure of serial neurofilament light chain assessments in blood is a predictor of long-term disability progression in relapsing-remitting multiple sclerosis
ECTRIMS Online Library, Jens Kuhle, 229067
Safety and effectiveness of less frequent dosing of natalizumab in relapsing remitting multiple sclerosis (RRMS) patients in a dedicated MS center in Greece - an eleven years experience
ECTRIMS Online Library, Clementine Karageorgiou, 229082
False positive B viral hepatitis testing in MS patients receiving high dose of biotin
ECTRIMS Online Library, Valerie Pourcher, 229083
Improvements across functional systems are maintained regardless of early vs late confirmed disability improvement: CARE-MS 6-year follow-up
ECTRIMS Online Library, Patrick Vermersch, 229098
Fluorine-19 magnetic resonance imaging as a method for the individualized theranostic of fluorine labelled drugs in neuroinflammation
ECTRIMS Online Library, Christian Prinz, 229099
“Keep going!” Symptoms of depression, sleep disturbances, fatigue and anxiety improved 12 weeks after exercising and active leisure time activity, but decreased further 16 weeks later - evidence for a continuous exercising program
ECTRIMS Online Library, Dena Sadeghi Bahmani, 229114
Glatiramer acetate slows disability progression - final 10-year results from UK Risk Sharing Scheme
ECTRIMS Online Library, Sarah Al-Izki, 229115
Quantitative neuroimaging in multiple sclerosis (MS): which biomarker is the most reliable in the evaluation of MS-induced atrophy?
ECTRIMS Online Library, Elefterios Makras, 229130

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings